Clinical Trial Update: Performance Evaluation of a Non-Invasive Glucose Monitor as Compared to CGM Data Acquired by the iPro2

View source ↗

Summary

A completed clinical trial evaluating a non-invasive glucose monitor against CGM data from the iPro2 in individuals with Type 1 diabetes. The study assesses the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Sansum Diabetes Research Institute | Conditions: Type 1 Diabetes | Status: COMPLETED